What is centrolobular emphysema?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Centrolobular Emphysema

Centrolobular emphysema (CLE) is a specific type of emphysema characterized by destruction of respiratory bronchioles, alveolar ducts, and alveoli at the center of the acinus, while surrounding alveoli remain intact. 1

Pathological Features

  • CLE is one of the major patterns of emphysema, distinct from panacinar and paraseptal emphysema, with specific anatomical and functional consequences 1
  • It primarily affects the central portion of the secondary pulmonary lobule, sparing the peripheral alveoli 1
  • CLE is associated with more small airways disease and less loss of elastic recoil for any level of respiratory function compared to other emphysema types 1
  • Morphologically, CLE can be classified into three subtypes based on CT-pathologic correlations 2:
    • Type A: round or oval shape with well-defined borders (primarily related to bronchiolar dilatation)
    • Type B: polygonal or irregular shape with ill-defined borders (<5mm diameter), related to destruction of proximal alveolar ducts
    • Type C: irregular shape with ill-defined borders (≥5mm diameter), related to destruction of distal alveolar ducts

Clinical and Physiological Implications

  • CLE is strongly associated with cigarette smoking history (+21 pack-years compared to controls) 3
  • Patients with CLE experience greater dyspnea, reduced exercise capacity (measured by six-minute walk distance), and greater hyperinflation compared to those without emphysema 3
  • CLE demonstrates more significant airway abnormalities than other emphysema types, with thicker, narrower, and more reactive membranous bronchioles 4
  • Terminal bronchioles are significantly reduced in number and cross-sectional lumen area in CLE-dominant regions compared to mild emphysema or paraseptal emphysema-dominant regions 5
  • CLE is associated with steeper declines in diffusing capacity (DLCO) and transfer coefficient (KCO) across all GOLD stages of COPD, independent of age, sex, height, and smoking history 6
  • Moderate or severe CLE is linked to accelerated FEV1 decline and higher 10-year mortality in patients with severe COPD (GOLD stage 3 or higher) 6

Comparison with Other Emphysema Types

  • Unlike panacinar emphysema (which affects the entire acinus uniformly), CLE has uneven destruction focused on the central portion of the lobule 1, 4
  • Unlike paraseptal emphysema (which occurs adjacent to connective tissue septa), CLE affects the central portions of the secondary lobule 1
  • CLE shows greater neutrophilic inflammation compared to paraseptal emphysema 5
  • While panacinar emphysema is strongly associated with reduced body mass index, CLE is more strongly associated with smoking history 3
  • CLE has a stronger association with longitudinal decline in lung function and mortality compared to paraseptal emphysema 6

Diagnostic Considerations

  • High-resolution CT scanning is sufficiently sensitive to diagnose emphysema patterns, including CLE 1
  • CLE is the most common type of emphysema in COPD, with Type B (polygonal/irregular shape with ill-defined borders <5mm) being the most prevalent subtype (58% of patients) 2
  • CLE can be present in smokers even without spirometric evidence of COPD, which is independently associated with reduced exercise capacity 3

Clinical Significance

  • The presence of CLE has important prognostic implications, as it is associated with more rapid decline in diffusing capacity and higher mortality compared to other emphysema subtypes 6
  • Recognition of CLE on imaging is important for risk stratification and management planning in patients with COPD 1, 3
  • The distinct pathophysiology of CLE (airway-predominant disease) compared to panacinar emphysema (loss of elastic recoil) may have implications for targeted therapeutic approaches 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pathology of emphysema in chronic obstructive pulmonary disease.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.